Black Rock Inc. Nex Immune, Inc. Transaction History

Black Rock Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.26 - $0.47 $11,312 - $20,448	-43,508 Reduced 99.18%	360 $0
Q1 2023 May 12, 2023	BUY	$0.3 - $0.6 $419 - $838	1,398 Added 3.29%	43,868 $16,000
Q4 2022 Feb 13, 2023	BUY	$0.21 - $18.5 $2,756 - $242,849	13,127 Added 44.74%	42,470 $10,000
Q3 2022 Nov 14, 2022	SELL	$0.6 - $17.5 $8,760 - $255,517	-14,601 Reduced 33.23%	29,343 $16,000
Q2 2022 Aug 12, 2022	SELL	$1.61 - $4.68 $1.26 Million - $3.65 Million	-780,039 Reduced 94.67%	43,944 $72,000
Q1 2022 May 12, 2022	SELL	$1.79 - $4.65 $39,428 - $102,425	-22,027 Reduced 2.6%	823,983 $3.47 Million
Q4 2021 Feb 10, 2022	BUY	$4.11 - $15.13 $137,052 - $504,524	33,346 Added 4.1%	846,010 $3.9 Million
Q3 2021 Nov 09, 2021	BUY	$10.32 - $16.9 $5.04 Million - $8.25 Million	488,140 Added 150.42%	812,664 $12.3 Million
Q2 2021 Aug 11, 2021	BUY	$14.98 - $23.89 $4.86 Million - $7.75 Million	324,524 New	324,524 $5.3 Million

Ticker NEXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,155,600
Market Cap $5.07M
Description
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.